SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-076406
Filing Date
2024-06-21
Accepted
2024-06-21 18:18:17
Documents
2
Period of Report
2024-06-19

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3948
2 EX-24 antx-ex24.htm EX-24 12577
  Complete submission text file 0000950170-24-076406.txt   17981
Mailing Address C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
FitzPatrick Margaret M (Reporting) CIK: 0001873879 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41331 | Film No.: 241061652

Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)